These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28168767)

  • 1. Lifestyle change reduces cardiometabolic risk factors and glucagon-like peptide-1 levels in obese first-degree relatives of people with diabetes.
    Bowes A; Begley J; Kerr D
    J Hum Nutr Diet; 2017 Aug; 30(4):490-498. PubMed ID: 28168767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes.
    Santilli F; Simeone PG; Guagnano MT; Leo M; Maccarone MT; Di Castelnuovo A; Sborgia C; Bonadonna RC; Angelucci E; Federico V; Cianfarani S; Manzoli L; Davì G; Tartaro A; Consoli A
    Diabetes Care; 2017 Nov; 40(11):1556-1564. PubMed ID: 28912305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multifunctional diet improves cardiometabolic-related biomarkers independently of weight changes: an 8-week randomized controlled intervention in healthy overweight and obese subjects.
    Tovar J; Johansson M; Björck I
    Eur J Nutr; 2016 Oct; 55(7):2295-306. PubMed ID: 26370118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.
    Halperin F; Ding SA; Simonson DC; Panosian J; Goebel-Fabbri A; Wewalka M; Hamdy O; Abrahamson M; Clancy K; Foster K; Lautz D; Vernon A; Goldfine AB
    JAMA Surg; 2014 Jul; 149(7):716-26. PubMed ID: 24899464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O
    Ann Nutr Metab; 2007; 51(2):134-8. PubMed ID: 17536190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Components of the metabolic syndrome are negative predictors of weight loss in obese children with lifestyle intervention.
    Uysal Y; Wolters B; Knop C; Reinehr T
    Clin Nutr; 2014 Aug; 33(4):620-5. PubMed ID: 24075648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Sleeve Gastrectomy on Type 2 Diabetes Mellitus, Gastric Emptying Time, Glucagon-Like Peptide 1 (GLP-1), Ghrelin and Leptin in Non-morbidly Obese Subjects with BMI 30-35.0 kg/m
    Vigneshwaran B; Wahal A; Aggarwal S; Priyadarshini P; Bhattacharjee H; Khadgawat R; Yadav R
    Obes Surg; 2016 Dec; 26(12):2817-2823. PubMed ID: 27185177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes.
    Fujishima Y; Maeda N; Inoue K; Kashine S; Nishizawa H; Hirata A; Kozawa J; Yasuda T; Okita K; Imagawa A; Funahashi T; Shimomura I
    Cardiovasc Diabetol; 2012 Sep; 11():107. PubMed ID: 22973968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma level of glucagon-like peptide 1 in obese Egyptians with normal and impaired glucose tolerance.
    Hussein MS; Abushady MM; Refaat S; Ibrahim R
    Arch Med Res; 2014 Jan; 45(1):58-62. PubMed ID: 24321596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of GLP-1 analogues in obese, insulin-using type 2 diabetes in relation to eating behaviour.
    de Boer SA; Lefrandt JD; Petersen JF; Boersma HH; Mulder DJ; Hoogenberg K
    Int J Clin Pharm; 2016 Feb; 38(1):144-51. PubMed ID: 26597956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
    Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A
    Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of progressive resistance training combined with a whey-protein drink and vitamin D supplementation on glycaemic control, body composition and cardiometabolic risk factors in older adults with type 2 diabetes: study protocol for a randomized controlled trial.
    Daly RM; Miller EG; Dunstan DW; Kerr DA; Solah V; Menzies D; Nowson CA
    Trials; 2014 Nov; 15():431. PubMed ID: 25376884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of basal insulin analog and metformin on glycaemia control and weight as risk factors for endothelial dysfunction.
    Ascić-Buturović B; Kacila M
    Bosn J Basic Med Sci; 2008 Nov; 8(4):309-12. PubMed ID: 19125700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body weight course in the DIAbetes and LifEstyle Cohort Twente (DIALECT-1)-A 20-year observational study.
    Gant CM; Mensink I; Binnenmars SH; van der Palen JAM; Bakker SJL; Navis G; Laverman GD
    PLoS One; 2019; 14(6):e0218400. PubMed ID: 31216324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between changes in glucagon-like peptide-1 and bodyweight reduction in patients receiving acarbose or metformin treatment.
    Wang N; Zhang JP; Xing XY; Yang ZJ; Zhang B; Wang X; Yang WY
    J Diabetes; 2017 Aug; 9(8):728-737. PubMed ID: 27717194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of improved fitness beyond weight loss on cardiovascular risk factors in individuals with type 2 diabetes in the Look AHEAD study.
    Gibbs BB; Brancati FL; Chen H; Coday M; Jakicic JM; Lewis CE; Stewart KJ; Clark JM;
    Eur J Prev Cardiol; 2014 May; 21(5):608-17. PubMed ID: 23012688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PULSE (Prevention Using LifeStyle Education) trial protocol: a randomised controlled trial of a Type 2 Diabetes Prevention programme for men.
    Aguiar EJ; Morgan PJ; Collins CE; Plotnikoff RC; Young MD; Callister R
    Contemp Clin Trials; 2014 Sep; 39(1):132-44. PubMed ID: 25092484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss.
    Simeone P; Liani R; Tripaldi R; Di Castelnuovo A; Guagnano MT; Tartaro A; Bonadonna RC; Federico V; Cipollone F; Consoli A; Santilli F
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of meal composition on postprandial glucagon-like peptide-1, insulin, glucagon, C-peptide, and glucose responses in overweight/obese subjects.
    Shah M; Franklin B; Adams-Huet B; Mitchell J; Bouza B; Dart L; Phillips M
    Eur J Nutr; 2017 Apr; 56(3):1053-1062. PubMed ID: 26759261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.
    Laferrère B; Teixeira J; McGinty J; Tran H; Egger JR; Colarusso A; Kovack B; Bawa B; Koshy N; Lee H; Yapp K; Olivan B
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2479-85. PubMed ID: 18430778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.